Abstract
During 2011, 62 samples of baby formulae were checked for aflatoxin M1 (AFM1) and ochratoxin A (OTA) by immunoaffinity column (IAC) clean-up and high performance liquid chromatography with fluorescence detection (HPLC-FD). The limits of detection (LOD) and quantification (LOQ) of the analytical method were 0.005 μg kg−1 and 0.018 μg kg−1 for AFM1 and 0.006 μg kg−1 and 0.021 μg kg−1 for OTA, respectively. The recovery of AFM1 from formulae ranged between 84.27% and 88.21% (RSD = 3.54–6.18%), while the mean recoveries of OTA varied from 79.21% to 86.38% (RSD = 4.47–7.11%).Aflatoxin M1 was detected in five (8%) of formula samples, but at levels below the European legislation limit of 0.025 μg kg−1, with concentrations ranging from 0.016 to 0.022 μg kg−1 (mean level: 0.018 μg kg−1). Ochratoxin A was detected in 12 out of the 62 samples (19.4%), at levels ranging from 0.017 to 0.184 μg kg−1 (mean level: 0.103 μg kg−1). None of the samples exceeded the maximum limit for OTA set by European Commission Regulation (0.5 μg kg−1). The co-occurrence of AFM1 and OTA was present in only one sample (1.6%). The estimated daily intakes of AFM1 and OTA through formulae were in the range of 0.08–0.021 ng kg−1 b.w. and 0.034–0.305 ng kg−1 b.w., respectively. On the basis of current knowledge, it can be concluded that there is no considerable risk of AFM1 and OTA exposure for the Turkish babies and young children.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.